Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Invested Capital: 2009-2024

Historic Invested Capital for Rockwell Medical (RMTI) over the last 16 years, with Dec 2024 value amounting to $34.1 million.

  • Rockwell Medical's Invested Capital rose 23.04% to $37.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.9 million, marking a year-over-year increase of 23.04%. This contributed to the annual value of $34.1 million for FY2024, which is 45.93% up from last year.
  • Per Rockwell Medical's latest filing, its Invested Capital stood at $34.1 million for FY2024, which was up 45.93% from $23.4 million recorded in FY2023.
  • Rockwell Medical's Invested Capital's 5-year high stood at $55.1 million during FY2020, with a 5-year trough of $23.1 million in FY2021.
  • Its 3-year average for Invested Capital is $26.9 million, with a median of $23.4 million in 2023.
  • As far as peak fluctuations go, Rockwell Medical's Invested Capital spiked by 168.52% in 2020, and later tumbled by 57.99% in 2021.
  • Over the past 5 years, Rockwell Medical's Invested Capital (Yearly) stood at $55.1 million in 2020, then tumbled by 57.99% to $23.1 million in 2021, then climbed by 0.74% to $23.3 million in 2022, then rose by 0.31% to $23.4 million in 2023, then soared by 45.93% to $34.1 million in 2024.